Literature DB >> 26927757

Readmissions after major gynecologic oncology surgery.

Shitanshu Uppal1, Courtney Penn2, Marcela G Del Carmen3, J Alejandro Rauh-Hain3, R Kevin Reynolds2, Laurel W Rice4.   

Abstract

OBJECTIVES: To examine the underlying indications, timing, and risk factors associated with unplanned hospital readmissions after major surgery for a gynecologic malignancy.
METHODS: This is a retrospective database cohort study utilizing the National Surgical Quality Improvement Program database (NSQIP). The association between risk factors with respect to 30-day unplanned readmission was modeled using logistic regression. Timing of readmission and the primary reason of readmission was abstracted from the database.
RESULTS: Overall, the unplanned readmission rate was 6.5% (832/12,804). On multivariate analysis, operative time≥3h (OR 1.39, p<0.001), open abdominal surgery (OR 2.2, p<0.001), any complication prior to discharge (OR 1.6, p<0.001), two or more additional surgical procedures (OR 1.34, p=0.003), or cervical cancer as the site of primary disease (OR 1.30, p=0.05) were noted to be independent predictors of readmission. To provide a convenient calculation of overall probability of readmission, we developed a nomogram of factors significantly predicting readmission. Overall, infections were a cause of 45% of the readmissions. Surgical Site Infections were the most common reason, accounting for 29.2% of all readmissions. A majority of the readmissions (approximately 75%) were within two weeks of discharge from the hospital.
CONCLUSIONS: Efforts to reduce readmission rates should focus on identifying patients at a high risk of readmission and reducing surgical site infections. Additionally, prospective evaluation of interventions targeted at reducing readmissions should focus on the first two weeks after discharge from the hospital.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26927757     DOI: 10.1016/j.ygyno.2016.02.031

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?

Authors:  Emma L Barber; Kemi M Doll; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2017-05-16       Impact factor: 5.482

Review 2.  Society of gynecologic oncology future of physician payment reform task force: Lessons learned in developing and implementing surgical alternative payment models.

Authors:  Margaret I Liang; Emeline M Aviki; Jason D Wright; Laura J Havrilesky; Leslie R Boyd; Haley A Moss; Elizabeth L Jewell; David E Cohn; Sachin M Apte; Patrick F Timmins; Ronald D Alvarez; Jill Rathbun; Elizabeth Lipinski; Susan White; Dorimar Siverio-Minardi; Emily M Ko
Journal:  Gynecol Oncol       Date:  2020-01-06       Impact factor: 5.482

3.  Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections.

Authors:  Simona Di Giambenedetto; Alberto Borghetti; Lorena Quagliozzi; Valeria Gallucci; Francesca Lombardi; Arturo Ciccullo; Anna Fagotti; Enrica Tamburrini; Giovanni Scambia
Journal:  J Pers Med       Date:  2022-04-18

Review 4.  Pushing the Envelope: Laparoscopic Nephrectomy as Outpatient Surgery.

Authors:  Nessn H Azawi; Tom Christensen; Claus Dahl; Lars Lund
Journal:  Curr Urol Rep       Date:  2018-01-27       Impact factor: 3.092

5.  Unplanned Readmission in Outpatient Hand Surgery: An Analysis of 23,613 Patients in the NSQIP Data Set.

Authors:  Daniel P Donato; Alvin C Kwok; Michael O Bishop; Angela P Presson; Jayant P Agarwal
Journal:  Eplasty       Date:  2017-12-06

6.  Stopping the revolving door: An exploratory analysis of health care super-utilization in gynecologic oncology.

Authors:  Catherine N Zivanov; Annie Apple; Alaina J Brown; Marc A Robinson; Lauren S Prescott
Journal:  Gynecol Oncol Rep       Date:  2021-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.